United StatesOverall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Obstetrics & Reproductive Medicine
Rank in SubField 1: 4,777 out of 355,674 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 126,232 | 127,096 |
| Total Cites | 8,641 | 9,534 |
| H-index | 45 | 47 |
| Hm-index | 16 | 18 |
| Number of Single Authored Papers | 5 | 5 |
| Total Cites to Single Authored Papers | 22 | 27 |
| Number of Single+First Authored Papers | 34 | 34 |
| Total Cites to Single+First Authored Papers | 1,802 | 1,974 |
| Number of Single+First+Last Authored Papers | 81 | 81 |
| Total Cites to Single+First+Last Authored Papers | 2,500 | 2,750 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 7,189 | 7,725 |
| Ratio of Total Citations to Distinct Citing Papers | 1.20 | 1.23 |
| Self-Citation Percentage |
9.37%
|
|
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Obstetrics & Reproductive Medicine
Rank in SubField 1: 5,017 out of 334,837 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 132,191 | 135,546 |
| Total Cites | 7,579 | 8,376 |
| H-index | 42 | 45 |
| Hm-index | 15 | 16 |
| Number of Single Authored Papers | 5 | 5 |
| Total Cites to Single Authored Papers | 21 | 24 |
| Number of Single+First Authored Papers | 33 | 33 |
| Total Cites to Single+First Authored Papers | 1,668 | 1,828 |
| Number of Single+First+Last Authored Papers | 74 | 74 |
| Total Cites to Single+First+Last Authored Papers | 2,236 | 2,458 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 6,307 | 6,790 |
| Ratio of Total Citations to Distinct Citing Papers | 1.20 | 1.23 |
| Self-Citation Percentage |
9.52%
|
|
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Obstetrics & Reproductive Medicine
Rank in SubField 1: 5,234 out of 312,644 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 137,466 | 144,334 |
| Total Cites | 6,694 | 7,418 |
| H-index | 41 | 42 |
| Hm-index | 14 | 15 |
| Number of Single Authored Papers | 5 | 5 |
| Total Cites to Single Authored Papers | 18 | 21 |
| Number of Single+First Authored Papers | 33 | 33 |
| Total Cites to Single+First Authored Papers | 1,556 | 1,712 |
| Number of Single+First+Last Authored Papers | 70 | 70 |
| Total Cites to Single+First+Last Authored Papers | 2,003 | 2,208 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 5,579 | 6,016 |
| Ratio of Total Citations to Distinct Citing Papers | 1.20 | 1.23 |
| Self-Citation Percentage |
9.76%
|
|
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Obstetrics & Reproductive Medicine
Rank in SubField 1: 5,361 out of 293,195 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 141,210 | 147,259 |
| Total Cites | 5,707 | 6,354 |
| H-index | 39 | 41 |
| Hm-index | 14 | 14 |
| Number of Single Authored Papers | 5 | 5 |
| Total Cites to Single Authored Papers | 16 | 19 |
| Number of Single+First Authored Papers | 33 | 33 |
| Total Cites to Single+First Authored Papers | 1,419 | 1,567 |
| Number of Single+First+Last Authored Papers | 65 | 65 |
| Total Cites to Single+First+Last Authored Papers | 1,756 | 1,949 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 4,749 | 5,137 |
| Ratio of Total Citations to Distinct Citing Papers | 1.20 | 1.24 |
| Self-Citation Percentage |
10.18%
|
|
Trending Researchers
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.